After a 14-year process, carfilzomib, a cancer drug developed from a natural product by Dr. Craig Crews’ lab, has received FDA approval.
Based on recent trials, gene therapy may provide a new avenue for treating the serious immune disorder ADA-SCID.
The recent Autism Phenome Project has identified a correlation between autism and overgrowth, but the genetic connection remains unclear.
A recent FDA admission about the wrongful approval of a knee implant has sparked controversy about the agency’s priorities: how can it balance safety with efficiency?
As a Yale undergraduate, Jennifer Staple-Clark founded Unite for Sight, which has grown into an international organization that provides eye care and resources to hundreds of thousands.
Professor Tamas Horvath and his research team have found that natural birth stimulates production of a protein that helps neurons, especially those involved in memory, form connections.
Omar Samad and Dr. Stephen Waxman have developed a potential method to treat neuropathic pain by reducing the production of a specific sodium channel.
Alanna Schepartz and Andy Phillips have received a grant to research compounds that affect proteins involved in cancer, such as p53.
Bioethicist and Yale Professor Dr. Robert Levine believes that use of placebos in clinical research is ethical, but only under the right circumstances.
Dr. Judson Brewer of the Yale Medical School has shown that meditation decreases activity of the parts of the mind associated with self-referential processing and mind-wandering.